97-12257. New Animal Drugs for Use in Animal Feeds; Medicated Feed Applications; Semduramicin  

  • [Federal Register Volume 62, Number 90 (Friday, May 9, 1997)]
    [Rules and Regulations]
    [Page 25477]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-12257]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 558
    
    
    New Animal Drugs for Use in Animal Feeds; Medicated Feed 
    Applications; Semduramicin
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
    drug regulations to reflect approval of a supplemental new animal drug 
    application (NADA) filed by Pfizer, Inc. The supplemental NADA provides 
    for revised assay limits for Type C medicated semduramicin chicken feed 
    to 80 to 110 percent of labeled claim.
    
    EFFECTIVE DATE: May 9, 1997.
    
    FOR FURTHER INFORMATION CONTACT: William G. Marnane, Center for 
    Veterinary Medicine (HFV-140), Food and Drug Administration, 7500 
    Standish Pl., Rockville, MD 20855, 301-594-0678.
    
    SUPPLEMENTARY INFORMATION: Pfizer, Inc., 235 East 42d St., New York, NY 
    10017, filed supplemental NADA 140-940, which provides for revising the 
    assay limits for Type C medicated chicken feed containing 
    AviaxTM (semduramicin sodium) from 85 to 110 percent of 
    labeled claim to 80 to 110 percent. The supplemental NADA is approved 
    as of April 8, 1997, and the regulations are amended in 21 CFR 558.4(d) 
    to reflect the approval.
        Revision of the assay limits for a Type C medicated feed is based 
    on the evaluation of the assay procedure used to analyze the feed and 
    analysis of the assays of those feeds. The initial assay limits were 
    established based on the results of the method trial. Evaluation of the 
    feeds used in the market support trials, comparable to commercial 
    manufacturing operations, support a wider assay range. This action did 
    not require reevaluation of the safety and effectiveness data 
    supporting the original approval. Therefore, a freedom of information 
    summary is not required.
    
    List of Subjects in 21 CFR Part 558
    
        Animal drugs, Animal feeds.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs and 
    redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is 
    amended as follows:
    
    PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
    
        1. The authority citation for 21 CFR part 558 continues to read as 
    follows:
    
        Authority: Secs. 512, 701 of the Federal Food, Drug, and 
    Cosmetic Act (21 U.S.C. 360b, 371).
    
    
    Sec. 558.4  [Amended]
    
        2. Section 558.4 Medicated feed applications is amended in 
    paragraph (d), in the table entitled ``Category I,'' in the entry for 
    ``Semduramicin,'' in the last column by removing the assay limits ``85-
    110'' and adding in its place ``80-110.''
    
        Dated: April 30, 1997.
    Robert C. Livingston,
    Director, Office of New Animal Drug Evaluation, Center for Veterinary 
    Medicine.
    [FR Doc. 97-12257 Filed 5-8-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
5/9/1997
Published:
05/09/1997
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
97-12257
Dates:
May 9, 1997.
Pages:
25477-25477 (1 pages)
PDF File:
97-12257.pdf
CFR: (1)
21 CFR 558.4